ExodusPoint Capital Management, LP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2022$19,000
-76.5%
12,780
-56.5%
0.00%
-100.0%
Q4 2021$81,000
-42.6%
29,385
+25.1%
0.00%
-50.0%
Q3 2021$141,000
+187.8%
23,485
+18.1%
0.00%
+100.0%
Q1 2021$49,00019,8850.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders